Interstitial lung disease associated with juvenile dermatomyositis: Clinical features and efficacy of cyclosporin A

Rheumatology

Volumn 42, Issue 2, 2003, Pages 371-374

  Kobayashi, I ^a   Yamada, M ^a   Takahashi, Y ^a   Kawamura, N ^a   Okano, M ^a   Sakiyama, Y ^a   Kobayashi, K ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bronchiolitis obliterans organizing pneumonia; Cylosporin A; Interstitial lung disease; Interstitial pneumonia; Juvenile dermatomyositis; KL 6

Indexed keywords

ANTINUCLEAR ANTIBODY; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE;

ADOLESCENT; ARTICLE; BRONCHIOLITIS; CATARACT; CAUSE OF DEATH; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DERMATOMYOSITIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HIRSUTISM; HOSPITAL ADMISSION; HUMAN; IMMUNOASSAY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; MALE; MEDICAL RECORD; NEPHROTOXICITY; ONSET AGE; OSTEOPOROSIS; PRIORITY JOURNAL; RESPIRATORY FAILURE; SYMPTOMATOLOGY; THORAX RADIOGRAPHY; THROMBOCYTOPENIA; UNIVERSITY HOSPITAL;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS; BRONCHIOLITIS OBLITERANS ORGANIZING PNEUMONIA; CHILD; CHILD, PRESCHOOL; CYCLOSPORINE; DERMATOMYOSITIS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG DISEASES, INTERSTITIAL; MALE; PREDNISOLONE; PROGNOSIS; VITAL CAPACITY;

EID: 0344837918     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg040     Document Type: Article

References (16)

1. Bohan A, Peters JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
2. Pachman LM. Juvenile dermatomyositis. Pathology and disease expression. Pediatr Clin North Am 1995; 42:1071-98.
3. Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: Analysis of six cases and review of the literature. Medicine 1976;55:89-104.
4. Takizawa H, Shiga J, Moroi Y, Miyauchi S, Nishiwaki M, Miyamoto T. Interstitial lung disease in dermatomyositis: clinicopathological study. J Rheumatol 1987; 14:102-7.
5. Trapani S, Camiciottoli G, Vierucci A, Pistolesi M, Falcini F. Pulmonary involvement in juvenile dermatomyositis: a two-year longitudinal study. Rheumatology 2001;40:216-20.
6. Park S, Nyhan WL. Fatal pulmonary involvement in dermatomyositis. Am J Dis Child 1975;129:723-6.
7. Singsen BH, Tedford JC, Platzker ACG, Hanson V. Spontaneous pneumothorax: A complication of juvenile dermatomyositis. J Pediatr 1978;92:771-4.
8. Chmiel JF, Wessel HU, Targoff IN, Pachman LM. Pulmonary fibrosis and myositis in a child with anti-Jo-1 antibody. J Rheumatol 1995;22:762-5.
9. Al-Mayouf SM, Al-Eid W, Bahabri S, Al-Mofada S. Interstitial pneumonitis and air leakage in juvenile dermatomyositis. Rheumatology 2001;40:588-91.
10. Kobayashi I, Ono S, Kawamura N et al. KL-6 is a potential marker for interstitial lung disease associated with juvenile dermatomyositis. J Pediatr 2001;138:274-6.
11. Pistoia V, Buoncompagni A, Scribanis R et al. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Result of a preliminary study. Clin Exp Rheumatol 1993;11:203-8.
12. Reiff A, Rawlings DJ, Shaham B et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. J Rheumatol 1997; 24:2436-43.
13. Maeda K, Kimura R, Komuta K, Igarashi T. Cyclosporine treatment for polymyositis/dermatomyositis: is it possible to rescue the deteriorating cases with interstitial pneumonitis? Scand J Rheumatol 1997;26:24-9.
14. Kohno N, Kyoizumi S, Awaya Y, Fukuhara H, Yamakido M, Akiyama M. New serum indicator of interstitial pneumonitis activity; sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73.
15. Johkoh T, Müler NL, Cartier Y et al. Idiopathic interstitial pneumonias: Diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999;211:555-60.
16. Zissel G, Ernst M, Schlaak M, Muller-Quernheim J. Pharmacological modulation of the IFNgamma-induced accessory function of alveolar macrophages and peripheral blood monocytes. Inflamm Res 1999;48:662-8.